Bray Capital Advisors - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bray Capital Advisors ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$47,569
+0.9%
4670.0%0.01%0.0%
Q2 2023$47,125
+9.7%
4670.0%0.01%
+7.7%
Q1 2023$42,964
+1.4%
4670.0%0.01%0.0%
Q4 2022$42,366
+21.0%
4670.0%0.01%
+18.2%
Q3 2022$35,000
-10.3%
4670.0%0.01%
-8.3%
Q2 2022$39,000
-4.9%
4670.0%0.01%
+9.1%
Q1 2022$41,0000.0%4670.0%0.01%
+10.0%
Q4 2021$41,000
+7.9%
4670.0%0.01%0.0%
Q3 2021$38,000
-11.6%
4670.0%0.01%
-9.1%
Q2 2021$43,000
+7.5%
4670.0%0.01%0.0%
Q1 2021$40,000
-9.1%
4670.0%0.01%
-15.4%
Q4 2020$44,000
+7.3%
4670.0%0.01%
-7.1%
Q3 2020$41,0000.0%4670.0%0.01%
-12.5%
Q2 2020$41,000
+5.1%
4670.0%0.02%
-11.1%
Q1 2020$39,000
-11.4%
4670.0%0.02%
+12.5%
Q4 2019$44,000
-2.2%
467
-9.8%
0.02%
-11.1%
Q3 2019$45,000
-4.3%
5180.0%0.02%0.0%
Q2 2019$47,000
-6.0%
5180.0%0.02%
-14.3%
Q1 2019$50,000
+25.0%
518
+10.9%
0.02%
+5.0%
Q4 2018$40,0000.0%4670.0%0.02%
+11.1%
Q3 2018$40,000
+14.3%
4670.0%0.02%
+12.5%
Q2 2018$35,000
-7.9%
4670.0%0.02%
-11.1%
Q1 2018$38,000
-84.4%
467
-86.1%
0.02%
-91.5%
Q1 2016$244,000
-15.9%
3,3670.0%0.21%
+15.2%
Q4 2015$290,000
-6.1%
3,3670.0%0.18%
-6.1%
Q3 2015$309,000
-6.6%
3,3670.0%0.20%
+3.2%
Q2 2015$331,000
-0.3%
3,3670.0%0.19%
-3.6%
Q1 2015$332,000
-4.3%
3,367
-10.2%
0.20%
-12.4%
Q4 2014$347,0003,7490.22%
Other shareholders
NOVARTIS A G shareholders Q2 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders